Associate Professor, Ophthalmology, Stanford University Medical Center
Ophthalmology
Dr. Christopher N. Ta, MD
|
|
Give Review
Doctor Christopher N. Ta, MD practices Ophthalmology. He went to medical school at University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Dr. Christopher N. Ta is a published doctor and has 65 publications published. The lastest was: 'Biocompatibility of poly(ethylene glycol) and poly(acrylic acid) interpenetrating network hydrogel by intrastromal implantation in rabbit cornea.' Doctor Christopher N. Ta, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Biocompatibility of poly(ethylene glycol) and poly(acrylic acid) interpenetrating network hydrogel by intrastromal implantation in rabbit cornea.
- Interpenetrating polymer network hydrogel scaffolds for artificial cornea periphery.
- Incidence of postoperative Endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution.
- INTRAVITREAL INJECTION TECHNIQUE AND MONITORING: Updated Guidelines of an Expert Panel.
- Successful DMEK After Intraoperative Graft Inversion.
- Prevention and treatment of injection-related Endophthalmitis.
- Application of 10% povidone iodine reduces conjunctival bacterial contamination rate in patients undergoing Cataract surgery.
- Prevention of postcataract Endophthalmitis: evidence-based medicine.
- Toward the development of an artificial cornea: Improved stability of interpenetrating polymer networks.
- Long-term clinical course of dry eye in patients with chronic graft-versus-host disease referred for eye examination.
- Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections.
- Morphology of Photopolymerized End-linked Poly(ethylene glycol) Hydrogels by Small Angle X-ray Scattering.
- One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus.
- Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria.
- A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections.
- Bioactive interpenetrating polymer network hydrogels that support Corneal epithelial wound healing.
- Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora.
- Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a one-day or one-hour application.
- Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections.
- Development of hydrogel-based keratoprostheses: a materials perspective.
- Progress in the development of interpenetrating polymer network hydrogels.
- Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental Endophthalmitis.
- A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora.
- Prospective comparative evaluation of povidone-iodine (10% for 5 minutes versus 5% for 1 minute) as prophylaxis for ophthalmic surgery.
- Prospective study demonstrating the efficacy of combined preoperative three-day application of antibiotics and povidone-iodine irrigation.
- Design and fabrication of an artificial cornea based on a photolithographically patterned hydrogel construct.
- Aspergillus fumigatus Keratitis following laser in situ keratomileusis.
- Topical antibiotic prophylaxis in intraocular injections.
- Endophthalmitis prophylaxis.
- Use of rapid antibiotic susceptibility testing in bacterial Endophthalmitis.
- Antibiotic susceptibility of preoperative normal conjunctival bacteria.
- Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for Anterior segment intraocular surgery.
- Comparison of preoperative conjunctival bacterial flora in patients undergoing glaucoma or Cataract surgery.
- Minimizing the risk of Endophthalmitis following intravitreous injections.
- Three-day application of topical ofloxacin reduces the contamination rate of microsurgical knives in Cataract surgery: a prospective randomized study.
- The challenge of determining aqueous contamination rate in Anterior segment intraocular surgery.
- Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing Anterior segment surgery.
- Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic Blepharitis.
- Nodular Scleritis in a patient with pyoderma gangrenosum.
- Evaluation and management of herpes zoster ophthalmicus.
- Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for Cataract surgery.
- Bilateral Mycobacterium abscessus Keratitis after laser in situ keratomileusis.
- Rapid direct antibiotic susceptibility testing in Endophthalmitis.
- Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery.
- A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.
- Glucose-permeable interpenetrating polymer network hydrogels for Corneal implant applications: a pilot study.
- Normal ocular flora in newborns delivered in two hospital centers in Argentina and Paraguay.
- Clinical results of topical fluconazole for the treatment of filamentous fungal Keratitis.
- Glucose permeability of human, bovine, and porcine corneas in vitro.
- Intravenous imipenem prophylaxis in experimental Endophthalmitis.
- Intravenous treatment of experimental Staphylococcus aureus Endophthalmitis: imipenem versus the combination of ceftazidime and amikacin.
- Epidemiological characteristics of microbiological results on patients with infectious Corneal ulcers: a 13-year survey in Paraguay.
- Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus Endophthalmitis.
- Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery.
- Constitutive mutations of Agrobacterium tumefaciens transcriptional activator virG.
- Mutants of Agrobacterium tumefaciens with elevated vir gene expression.
- Hyphema caused by a metallic intraocular foreign body during magnetic resonance imaging.
- Prospective randomized study determining whether a 3-day application of ofloxacin results in the selection of fluoroquinolone-resistant coagulase-negative Staphylococcus.
- Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora.
- In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria.
- [The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].
- Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis Endophthalmitis in a rabbit model.
- Leber hereditary optic neuropathy associated with antiretroviral therapy for human immunodeficiency virus infection.
- Evolving guidelines for intravitreous injections.
Schools
Univ Of Mn Med Sch
Kaiser Permanente
Stanford University
University Tex Sw
Procedures Preformed
- Anterior Lamellar Keratoplasty (ALK)
- Anterior Vitrectomy
- Biopsy of Cornea
- Blepharorrhaphy
- View All
Conditions Treated
- Acute Endophthalmitis
- Anterior Scleritis
- Aphakia and Other Disorders of Lens
- Astigmatism
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
Education
-
Stanford University -
Kaiser Permanente Medical Group -
University of Minnesota Medical School
Hospital
-
Stanford Health Care
Drug Facts
| NPI NUMBER | 1609903020 | |
| NPPES Provider LastName | TA | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 943052200 | |
| NPPES Provider State | CA | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 1454.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609903020 |
| Last Name Of The Provider | TA |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Michael W. Gaynon, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter R. Egbert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tarek El-Sawy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose Dalma-Weiszhausz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack Kabak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles C. Lin, MD |
|
|
Dr. Henry B. Kistler Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren A. Crow, MD |
|
|
Dr. Janet J. Lee, MD |
|
|
Dr. Amila R. Silva, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lingmin He, MD
This Doctor is OpenDoctor Recommended.
|